Clinical Trial Update: Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy subjects comparing inhaled fluticasone furoate and GW642444 administered by inhalation and intravenously to understand …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• GW642444 (GW642444)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED